Editorial: IL-1 Inhibition

Front Pharmacol. 2019 Feb 12:10:87. doi: 10.3389/fphar.2019.00087. eCollection 2019.
No abstract available

Keywords: IL-1 (interleukin-1); IL-1 blockade; anakinra; autoinflammatory diseases; canakinumab; inflammatory chronic diseases; rheumatic diseases.

Publication types

  • Editorial